Analysis of Surgical Results for the Patients with Pulmonary Metastasis from Colorectal Carcinoma

대장암의 전이성 폐암의 수술 결과에 대한 분석

  • Sim, Hyung-Tae (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Yong-Hee (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Shin, Hong-Ju (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Chun, Mi-Sun (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Bae, Chi-Hoon (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Eung-Sirk (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Park, Seung-Il (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Dong-Kwan (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine)
  • 심형태 (울산대학교 의과대학 서울아산병원 흉부외과) ;
  • 김용희 (울산대학교 의과대학 서울아산병원 흉부외과) ;
  • 신홍주 (울산대학교 의과대학 서울아산병원 흉부외과) ;
  • 천미순 (울산대학교 의과대학 서울아산병원 흉부외과) ;
  • 배지훈 (울산대학교 의과대학 서울아산병원 흉부외과) ;
  • 이응석 (울산대학교 의과대학 서울아산병원 흉부외과) ;
  • 박승일 (울산대학교 의과대학 서울아산병원 흉부외과) ;
  • 김동관 (울산대학교 의과대학 서울아산병원 흉부외과)
  • Published : 2006.11.05

Abstract

Background: The lung is the most common site of metastatic colorectal cancer comprising 10% of all curative resection of colorectal cancer. The reported 5 year survival rate varies among institutions. The purpose of the present study was to present the retrospective analysis of colorectal metastatic lung cancer surgery at our institution. Material and Method: A total of 61 patients undergoing surgery for metastatic colorectal lung cancer between July 1996 and December 2003 were included in the present study. The stage of the primary colorectal cancer, site of pulmonary metastasis, method of lung resection, the number and size of the metastatic nodules, the recurrence rate, and survival were assessed. Result: The 3 and 5 year survival rates were 66% and 41%, respectively. No significant risk factors were identified among the studied variables by either univariate or multivariate analysis. The mean disease free survival rate was 17 months. The most common recurrent site was lung, and among these patients, 3 underwent a second operation and two are still alive. Conclusion: The results of the above data suggest that pulmonary resection of metastatic lung cancer in select patients after curative resection of colon cancer may be a good therapeutic option with the potential for excellent results.

배경: 폐는 대장암의 가장 흔한 복강 외 전이 장소이며, 폐 전이는 대장암의 근치적 수술 후 약 10%에서 발생된다고 알려져 있다. 폐 전이에 대한 수술 후 5년 생존율은 $9{\sim}47%$로 다양하게 보고되고 있으나 국내에서는 대장암의 폐 전이에 대한 임상연구가 미흡한 상태이다. 이에 저자들은 대장암의 근치적 수술 후 폐 전이가 발생한 환자에서 폐 절제술을 시행하고 그 결과를 후향적으로 분석하였다. 대상 및 방법: 대상 환자는 1996년 7월부터 2003년 12월까지 대장암의 폐 전이로 폐절제술을 시행 받은 61명을 대상으로 하였다. 연구는 대장암 병기, 폐 전이의 위치, 폐절제술의 방법, 전이된 폐 결절의 수와 크기, 재발, 생존 등을 조사하여 그 예후 인자를 알아보고자 하였다. 결과: 환자들의 평균 3년, 5년 생존율은 각각 61%, 41%였다. 단변량 및 다변량 분석에서 통계학적으로 유의한 예후 인자는 없었다. 환자들의 평균 무병 기간은 17개월이었다. 수술 후 재발은 폐가 가장 흔한 위치였고, 이 중 3명의 환자에서 재수술을 시행하여 2명은 현재까지 생존해 있다. 결론: 대장암의 근치적 수술 후 폐 전이 발생 시 수술적응이 되는 경우 폐절제술을 시행하는 것이 좋은 결과를 기대할 수 있는 적절한 치료방법이라고 생각한다.

Keywords

References

  1. McCormack PM, Attiyeh FF. Resected pulmonary metastases from colorectal cancer. Dis Colon Rectum 1979;22:553-6 https://doi.org/10.1007/BF02587003
  2. Ike H, Shimada H, Ohki S, Yamaguchi S, Ichikawa Y. Results of aggressive resection of lung metastases from colorectal carcinoma detected by intensive follow-up. Dis Colon Rectum 2002;45:468-75 https://doi.org/10.1007/s10350-004-6222-0
  3. Park IJ, Kim HC, Lee GH, et al. Pulmonary metastases after curative resection in patients with colorectal carcinomas. J Korean Soc Coloproctol 2003;19:307-13
  4. Windschitl H, Scott M, Schutt A, et al. Randomized phase II studies in advanced colorectal carcinoma: a north central cancer treatment group study. Cancer Treat Res 1983;67: 1001-8
  5. Leonard BS, John VC, Charles B, et al. Ironotecan plus fluorouracil and leucovorin for metastatic colorectaol cancer. N Engl J Med 2000;343:905-14 https://doi.org/10.1056/NEJM200009283431302
  6. Thomford NR, Woolner LB, Clagett OT. The surgical treatment of metastatic tumors in the lungs. J Thorac Cardiovasc Surg 1965;49:357-63
  7. Martini N, Huvos AG, Mike V, et al. Multiple pulmonary resections in the treatment of osteogenic sarcoma. Ann Thorac Surg 1971;12:271-80 https://doi.org/10.1016/S0003-4975(10)65124-7
  8. Rusch VW. Pulmonary metastasectomy. Current indication. Chest 1995;107:322-31 https://doi.org/10.1378/chest.107.6_Supplement.322S
  9. Pfannschmidt J, Muley T, Hoffmann H, Dienemann H. Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: experiences in 167 patients. J Thorac Cardiovasc Surg 2003;126:732-9 https://doi.org/10.1016/S0022-5223(03)00587-7
  10. Okumura S, Kondo H, Tsuboi M, et al. Pulmonary resection for metastatic colorectal cancer: experiences with 159 patients. J Thorac Cardiovasc Surg 1996;112:867-74 https://doi.org/10.1016/S0022-5223(96)70085-5
  11. McAfee MK, Allen MS, Trastek VF, et al. Colorectal lung metastases: results of surgical excision. Ann Thorac Surg 1992;53:780-6 https://doi.org/10.1016/0003-4975(92)91435-C
  12. Saito Y, Omiya H, Kohno K, et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J Thorac Cardiovasc Surg 2002;124:1007-13 https://doi.org/10.1067/mtc.2002.125165
  13. Inoue M, Ohta M, Iuchi K, et al. Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma. Ann Thorac Surg 2004;78:238-44 https://doi.org/10.1016/j.athoracsur.2004.02.017
  14. Higashiyama M, Kodama K, Higaki N, et al. Surgery for pulmonary metastases from colorectal cancer: the importance of prethoracotomy serum CEA as an indicator of prognosis. Jpn J Thorac Cardiovasc Surg 2003;51:289-96 https://doi.org/10.1007/BF02719380
  15. Mori M, Tomoda H, Ishida T, et al. Surgical resection of pulmonary metastases from colorectal adenocarcinoma. Arch Surg 1991;126:1297-302 https://doi.org/10.1001/archsurg.1991.01410340139020
  16. Shirouzu K, Isomoto H, Hayashi A, Nagamatsu Y, Kakegawa T. Surgical treatment for patients with pulmonary metastases after resection of primary colorectal carcinoma. Cancer 1995; 76:393-8 https://doi.org/10.1002/1097-0142(19950801)76:3<393::AID-CNCR2820760308>3.0.CO;2-8
  17. Sakamoto T, Tsubota N, Iwanaga K, et al. Pulmonary resection for metastases from colorectal cancer. Chest 2001;119: 1069-72 https://doi.org/10.1378/chest.119.4.1069
  18. Baron O, Amini M, Duveau D, et al. Surgical resection of pulmonary metastases from colorectal carcinoma. Eur J Cardiothorac Surg 1996;10:347-51 https://doi.org/10.1016/S1010-7940(96)80093-5
  19. Yano T, Hara N, Ichinose Y, et al. Results of pulmonary resection of metastatic colorectal cancer and its application. J Thorac Cardiovasc Surg 1993;106:875-9
  20. Cahan WG, Gastro EB, Hajdu SI. Therapeutic pulmonary resection of colonic carcinoma metastatic to lung. Dis Colom Rectum 1974;17:302-9 https://doi.org/10.1007/BF02586970
  21. McCormack PM, Bains MS, Beqq CB, et al. Role of videoassisted thoracic surgery in the treatment of pulmonary metastases: results of a prospective trial. Ann Thorac Surg 1996;62:213-6 https://doi.org/10.1016/0003-4975(96)00253-6
  22. Landreneau RJ, De Giacomo T, Mark MJ, et al. Therapeutic video-assisted thoracoscopic surgical resection of colorectal pulmonary metastases. Eur J Cardiothorac Surg 2000;18:671-7 https://doi.org/10.1016/S1010-7940(00)00580-7
  23. Jaklitsch MT, Mery CM, Lukanich JM, et al. Sequential thoracic metastasectomy prolongs survival by re-establishing local control within the chest. J Thorac Cardiovasc Surg 2001; 121:657-67 https://doi.org/10.1067/mtc.2001.112822